Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

New antibody-drug tech licensed by Asahi Kasei targets cancer cells precisely

  • Posted on May 27, 2026
  • By Google News
  • 0 Views
  • 1 min read
New antibody-drug tech licensed by Asahi Kasei targets cancer cells precisely
New antibody-drug tech licensed by Asahi Kasei targets cancer cells precisely

Dual-payload ADCs enable precise drug-to-antibody control, as Asahi Kasei works toward commercialization, potential sub-licensing and research.
continue reading...

Author
Google News

You May Also Like